Short-term LPS induces aortic valve thickening in ApoE*3Leiden mice.

Abstract

Recently, it was shown that 12weeks of lipopolysaccharide (LPS) administration to nonatherosclerotic mice induced thickening of the aortic heart valve (AV). Whether such effects may also occur even earlier is unknown. As most patients with AV stenosis also have atherosclerosis, we studied the short-term effect of LPS on the AVs in an atherosclerotic mouse model. ApoE*3Leiden mice, on an atherogenic diet, were injected intraperitoneally with either LPS or phosphate buffered saline (PBS), and sacrificed 2 or 15days later. AVs were assessed for size, fibrosis, glycosaminoglycans (GAGs), lipids, calcium deposits, iron deposits and inflammatory cells. LPS injection caused an increase in maximal leaflet thickness at 2days (128.4µm) compared to PBS-injected mice (67.8µm; P=0.007), whereas at 15days this was not significantly different. LPS injection did not significantly affect average AV thickness on day 2 (37.8µm), but did significantly increase average AV thickness at day 15 (41.6µm; P=0.038) compared to PBS-injected mice (31.7 and 32.3µm respectively). LPS injection did not affect AV fibrosis, GAGs and lipid content. Furthermore, no calcium deposits were found. Iron deposits, indicative for valve haemorrhage, were observed in one AV of the PBS-injected group (a day 2 mouse; 9.1%) and in five AVs of the LPS-injected group (both day 2- and 15 mice; 29.4%). No significant differences in inflammatory cell infiltration were observed upon LPS injection. Short-term LPS apparently has the potential to increase AV thickening and haemorrhage. These results suggest that systemic inflammation can acutely compromise AV structure.